Up-regulation of hexokinaseII in myeloma cells: Targeting myeloma cells with 3-bromopyruvate

Journal of Bioenergetics and Biomembranes

Volumn 44, Issue 1, 2012, Pages 31-38

  Nakano, Ayako ^a   Miki, Hirokazu ^a   Nakamura, Shingen ^a   Harada, Takeshi ^a   Oda, Asuka ^a   Amou, Hiroe ^a   Fujii, Shiro ^a   Kagawa, Kumiko ^a   Takeuchi, Kyoko ^b   Ozaki, Shuji ^c   Matsumoto, Toshio ^a   Abe, Masahiro ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b TOKUSHIMA UNIVERSITY HOSPITAL   (Japan)

^c National Hospital Organization   (Japan)

Author keywords

3 bromopyruvate; Gycolysis; Hexokinase II; Multiple myeloma; Osteoclast

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ADENOSINE TRIPHOSPHATE; BROMOPYRUVIC ACID; ENZYME INHIBITOR; HEXOKINASE; HEXOKINASE ISOENZYME; LACTIC ACID; PROTEIN KINASE B; UNCLASSIFIED DRUG;

ARTICLE; BONE MARROW CELL; CANCER CELL; CANCER GROWTH; CANCER SURVIVAL; CELL DEATH; CELL STIMULATION; COCULTURE; CONTROLLED STUDY; DRUG TARGETING; ENZYME PHOSPHORYLATION; GLYCOLYSIS; HUMAN; HUMAN CELL; MYELOMA CELL; OSTEOCLAST; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; STROMA CELL; UPREGULATION;

ADENOSINE TRIPHOSPHATE; ANALYSIS OF VARIANCE; ANTINEOPLASTIC AGENTS, ALKYLATING; APOPTOSIS; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HEXOKINASE; HUMANS; IMMUNOHISTOCHEMISTRY; MULTIPLE MYELOMA; PYRUVATES; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84858706673     PISSN: 0145479X     EISSN: 15736881     Source Type: Journal    
DOI: 10.1007/s10863-012-9412-9     Document Type: Article

References (42)

1. Abe M (2011) Int J Hematol 94(4):334-343
2. Abe M, Hiura K, Wilde J, Moriyama K, Hashimoto T, Ozaki S et al (2002) Blood 100(6):2195-2202
3. Abe M, Hiura K,Wilde J, Shioyasono A, Moriyama K, Hashimoto T et al (2004) Blood 104(8):2484-2491
4. Abe M, Kido S, Hiasa M, Nakano A, Oda A, Amou H et al (2006) Leukemia 20(7):1313-1315
5. Asano J, Nakano A, Oda A, Amou H, Hiasa M, Takeuchi K et al (2011) Leukemia 25(7):1182-1188
6. Cairns RA, Harris IS, Mak TW (2011) Nat Rev Cancer 11(2):85-95
7. Chen Z, Zhang H, Lu W, Huang P (2009) Biochim Biophys Acta 1787 (5):553-560
8. Cheng L, Alexander R, Zhang S, Pan CX, MacLennan GT, Lopez- Beltran A et al (2011) Expert Rev Anticancer Ther 11(7):1131-1143
9. Choi SJ, Cruz JC, Craig F, Chung H, Devlin RD, Roodman GD et al (2000) Blood 96(2):671-675
10. de Figueiredo-Pontes LL, Pintao MC, Oliveira LC, Dalmazzo LF, Jacomo RH, Garcia AB et al (2008) Cytometry B Clin Cytom 74(3):163-168
11. Dean M (2009) J Mammary Gland Biol Neoplasia 14(1):3-9
12. Draoui N, Feron O (2011) Dis Model Mech 4(6):727-732
13. Ehrlich LA, Chung HY, Ghobrial I, Choi SJ, Morandi F, Colla S et al (2005) Blood 106(4):1407-1414
14. Fletcher JI, Haber M, Henderson MJ, Norris MD (2010) Nat Rev Cancer 10(2):147-156
15. Ge Y, Zhan F, Barlogie B, Epstein J, Shaughnessy J Jr, Yaccoby S (2006) Br J Haematol 133(1):83-92
16. Giuliani N, Colla S, Morandi F, Lazzaretti M, Sala R, Bonomini S et al (2005) Blood 106(7):2472-2483
17. Gottlob K, Majewski N, Kennedy S, Kandel E, Robey RB, Hay N (2001) Genes Dev 15(11):1406-1418
18. Hiasa M, Abe M, Nakano A, Oda A, Amou H, Kido S et al (2009) Blood 114(20):4517-4526
19. Kennedy KM, Dewhirst MW (2010) Future Oncol 6(1):127-148
20. Kim W, Yoon JH, Jeong JM, Cheon GJ, Lee TS, Yang JI et al (2007) Mol Cancer Ther 6(9):2554-2562
21. Ko YH, Pedersen PL, Geschwind JF (2001) Cancer Lett 173(1):83-91
22. Lunt SY, Vander Heiden MG (2011) Annu Rev Cell Dev Biol 27:441-464
23. Mahindra A, Hideshima T, Anderson KC (2010) Blood Rev 24(Suppl 1):S5-S11
24. Mathupala SP, Rempel A, Pedersen PL (1995) J Biol Chem 270 (28):16918-16925
25. Mathupala SP, Ko YH, Pedersen PL (2006) Oncogene 25(34):4777-4786
26. Mathupala SP, Ko YH, Pedersen PL (2009) Semin Canc Biol 19 (1):17-24
27. Nakano A, Tsuji D, Miki H, Cui Q, Sayed SM, Ikegame A et al (2011) PLoS One 6(11):e27222
28. Oshima T, Abe M, Asano J, Hara T, Kitazoe K, Sekimoto E et al (2005) Blood 106(9):3160-3165
29. Pedersen PL (2007a) J Bioenerg Biomembr 39(1):1-12
30. Pedersen PL (2007b) J Bioenerg Biomembr 39(3):211-222
31. Roodman GD (2010) J Bone Miner Metab 28(3):244-250
32. Shinohara Y, Ichihara J, Terada H (1991) FEBS Lett 291(1):55-57
33. Standal T, Abildgaard N, Fagerli UM, Stordal B, Hjertner O, Borset M et al (2007) Blood 109(7):3024-3030
34. Stiles BL (2009) Adv Drug Deliv Rev 61(14):1276-1282
35. Szakacs G, Paterson JK, Ludwig JA, Booth-Genthe C, Gottesman MM (2006) Nat Rev Drug Discov 5(3):219-234
36. Takeuchi K, Abe M, Hiasa M, Oda A, Amou H, Kido S et al (2010) PLoS One 5(3):e9870
37. Tian E, Zhan F, Walker R, Rasmussen E, Ma Y, Barlogie B et al (2003) N Engl J Med 349(26):2483-2494
38. Wolf A, Agnihotri S, Micallef J, Mukherjee J, Sabha N, Cairns R et al (2011) J Exp Med 208(2):313-326
39. Yaccoby S (2010) Br J Haematol 149(3):311-321
40. Yaccoby S, Wezeman MJ, Henderson A, Cottler-Fox M, Yi Q, Barlogie B et al (2004) Cancer Res 64(6):2016-2023
41. Yaccoby S, Pennisi A, Li X, Dillon SR, Zhan F, Barlogie B et al (2008) Leukemia 22(2):406-413
42. Zhang XD, Deslandes E, Villedieu M, Poulain L, Duval M, Gauduchon P et al (2006) Anticancer Res 26(5A):3561-3566